Posted inPress Releases
Glenmark Launches GLIPIQ Semaglutide in India With Focus on Affordable Type 2 Diabetes Care
Glenmark Pharmaceuticals has introduced GLIPIQ, a semaglutide-based treatment for Type 2 Diabetes Mellitus, in India, adding a new locally available option to the country's growing market for GLP-1 therapies. The…









